Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Sapropterin Dihydrochloride Supplementation on in Vivo Redox Status in Patients With Classical PKU

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01650909
Recruitment Status : Withdrawn (Withdrawn due to no funding)
First Posted : July 26, 2012
Last Update Posted : April 23, 2014
Sponsor:
Collaborator:
BioMarin Pharmaceutical
Information provided by (Responsible Party):
Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Primary Completion Date : No date given
Study Completion Date : No date given
Publications: